International union of basic and clinical pharmacology. LXXXVIII. g protein-coupled receptor list: Recommendations for new pairings with cognate Ligands

Pharmacological Reviews

Volumn 65, Issue 3, 2013, Pages 967-986

  Davenport, Anthony P ^a   Alexander, Stephen P H ^b   Sharman, Joanna L ^c   Pawson, Adam J ^c   Benson, Helen E ^c   Monaghan, Amy E ^c   Liew, Wen Chiy ^c   Mpamhanga, Chidochangu P ^c   Bonner, Tom I ^d   Neubig, Richard R ^e   Pin, Jean Philippe ^f   Spedding, Michael ^g   Harmar, Anthony J ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^g INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR GPR109A; G PROTEIN COUPLED RECEPTOR GPR109B; G PROTEIN COUPLED RECEPTOR GPR17; G PROTEIN COUPLED RECEPTOR GPR18; G PROTEIN COUPLED RECEPTOR GPR23; G PROTEIN COUPLED RECEPTOR GPR31; G PROTEIN COUPLED RECEPTOR GPR32; G PROTEIN COUPLED RECEPTOR GPR34; G PROTEIN COUPLED RECEPTOR GPR35; G PROTEIN COUPLED RECEPTOR GPR37; G PROTEIN COUPLED RECEPTOR GPR39; G PROTEIN COUPLED RECEPTOR GPR55; G PROTEIN COUPLED RECEPTOR GPR75; G PROTEIN COUPLED RECEPTOR GPR81; G PROTEIN COUPLED RECEPTOR GPR84; G PROTEIN COUPLED RECEPTOR GPR87; G PROTEIN COUPLED RECEPTOR GPR92; G PROTEIN COUPLED RECEPTOR P2Y5; HYDROXYCARBOXYLIC ACID RECEPTOR; KYNURENIC ACID; LACTIC ACID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLSERINE; OBESTATIN; PEPTIDOLEUKOTRIENE; PROTON; RESOLVIN D1; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL SURVIVAL; DIMERIZATION; FATTY ACID OXIDATION; GLUCOSE HOMEOSTASIS; LEUKOCYTE; LIGAND BINDING; MACROPHAGE; MIGRATION INHIBITION; MONOCYTE; NOMENCLATURE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PSEUDOGENE; RECEPTOR BINDING; REVIEW; TRANSGENIC ANIMAL; WNT SIGNALING PATHWAY;

ANIMALS; GENOTYPE; HUMANS; LIGANDS; PHENOTYPE; PSEUDOGENES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84878371294     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.112.007179     Document Type: Review

References (235)

1. Retraction (2005) Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 280:43280.
2. Adams JW, Wang J, Davis JR, Liaw C, Gaidarov I, Gatlin J, Dalton ND, Gu Y, Ross J Jr, and Behan D, et al. (2008) Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor. Am J Physiol Heart Circ Physiol 295:H509-H521.
3. Ahmed K, Tunaru S, Langhans CD, Hanson J, Michalski CW, Kölker S, Jones PM, Okun JG, and Offermanns S (2009) Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. J Biol Chem 284:21928-21933.
4. Ahmed K, Tunaru S, Tang C, Müller M, Gille A, Sassmann A, Hanson J, and Offermanns S (2010) An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metab 11:311-319.
5. Alenina N, Xu P, Rentzsch B, Patkin EL, and Bader M (2008) Genetically altered animal models for Mas and angiotensin-(1-7). Exp Physiol 93:528-537.
6. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, and Serhan CN (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178:3912-3917.
7. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, Hansen SH, and Hansen HS (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781:200-212.
8. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, ArenzanaSeisdedos F, Thelen M, and Bachelerie F (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280:35760-35766.
9. Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS, Whitfeld PL, Craig S, Corsini E, and Lu B, et al. (2010) The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem 285: 7633-7644.
10. Bechtold DA, Sidibe A, Saer BR, Li J, Hand LE, Ivanova EA, Darras VM, Dam J, Jockers R, and Luckman SM, et al. (2012) A role for the melatonin-related receptor GPR50 in leptin signaling, adaptive thermogenesis, and torpor. Curr Biol 22: 70-77.
11. Bender E, Buist A, Jurzak M, Langlois X, Baggerman G, Verhasselt P, Ercken M, Guo HQ, Wintmolders C, and Van den Wyngaert I, et al. (2002) Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. Proc Natl Acad Sci USA 99:8573-8578.
12. Benned-Jensen T and Rosenkilde MM (2010) Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants. Br J Pharmacol 159: 1092-1105.
13. Bodenmüller H and Schaller HC (1981) Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans. Nature 293:579-580.
14. Bohnekamp J, Böselt I, Saalbach A, Tönjes A, Kovacs P, Biebermann H, Manvelyan HM, Polte T, Gasperikova D, and Lkhagvasuren S, et al. (2010) Involvement of the chemokine-like receptor GPR33 in innate immunity. Biochem Biophys Res Commun 396:272-277.
15. Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, Wilson D, Xu Q, and Raz E (2008) Control of chemokine-guided cell migration by ligand sequestration. Cell 132:463-473.
16. Bolliger MF, Martinelli DC, and Südhof TC (2011) The cell-adhesion G proteincoupled receptor BAI3 is a high-affinity receptor for C1q-like proteins. Proc Natl Acad Sci USA 108:2534-2539.
17. Bondarenko A, Waldeck-Weiermair M, Naghdi S, Poteser M, Malli R, and Graier WF (2010) GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Br J Pharmacol 161:308-320.
18. Bondue B, Vosters O, de Nadai P, Glineur S, De Henau O, Luangsay S, Van Gool F, Communi D, De Vuyst P, and Desmecht D, et al. (2011a) ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. PLoS Pathog 7:e1002358.
19. Bondue B, Wittamer V, and Parmentier M (2011b) Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev 22:331-338.
20. Boucard AA, Ko J, and Südhof TC (2012) High affinity neurexin binding to cell adhesion G-protein-coupled receptor CIRL1/latrophilin-1 produces an intercellular adhesion complex. J Biol Chem 287:9399-9413.
21. Bratton DL and Henson PM (2008) Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up? Curr Biol 18:R76-R79.
22. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, and Fraser NJ, et al. (2003) The orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:11312-11319.
23. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, and Kuo CJ, et al. (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203:2201-2213.
24. Cai TQ, Ren N, Jin L, Cheng K, Kash S, Chen R, Wright SD, Taggart AK, and Waters MG (2008) Role of GPR81 in lactate-mediated reduction of adipose lipolysis. Biochem Biophys Res Commun 377:987-991.
25. Caminschi I, Vandenabeele S, Sofi M, McKnight AJ, Ward N, Brodnicki TC, Toy T, Lahoud M, Maraskovsky E, Shortman K, et al. (2006) Gene structure and transcript analysis of the human and mouse EGF-TM7 molecule, FIRE. DNA Seq 17: 8-14.
26. Canals M, Jenkins L, Kellett E, and Milligan G (2006) Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS. J Biol Chem 281:16757-16767.
27. Carmon KS, Gong X, Lin Q, Thomas A, and Liu Q (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci USA 108:11452-11457.
28. Cartoni C, Yasumatsu K, Ohkuri T, Shigemura N, Yoshida R, Godinot N, le Coutre J, Ninomiya Y, and Damak S (2010) Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci 30:8376-8382.
29. Cash JL, Christian AR, and Greaves DR (2010) Chemerin peptides promote phagocytosis in a ChemR23-and Syk-dependent manner. J Immunol 184:5315-5324.
30. Chartrel N, Alvear-Perez R, Leprince J, Iturrioz X, Reaux-Le Goazigo A, Audinot V, Chomarat P, Coge F, Nosjean O, and Rodriguez M, et al. (2007) Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315:766-, author reply 766.
31. Chen H and Ikeda SR (2004) Modulation of ion channels and synaptic transmission by a human sensory neuron-specific G-protein-coupled receptor, SNSR4/mrgX1, heterologously expressed in cultured rat neurons. J Neurosci 24:5044-5053.
32. Chiang N, Fredman G, Bäckhed F, Oh SF, Vickery T, Schmidt BA, and Serhan CN (2012) Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484:524-528.
33. Christiansen B, Hansen KB, Wellendorph P, and Bräuner-Osborne H (2007) Pharmacological characterization of mouse GPRC6A, an L-alpha-amino-acid receptor modulated by divalent cations. Br J Pharmacol 150:798-807.
34. Chu ZL, Carroll C, Chen R, Alfonso J, Gutierrez V, He H, Lucman A, Xing C, Sebring K, and Zhou J, et al. (2010) N-Oleoyldopamine enhances glucose homeostasis through the activation of GPR119. Mol Endocrinol 24:161-170.
35. Chun J, Hla T, Lynch KR, Spiegel S, and Moolenaar WH (2010) International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 62:579-587.
36. Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, and Gelosa P, et al. (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25:4615-4627.
37. Civelli O (2012) Orphan GPCRs and neuromodulation. Neuron 76:12-21.
38. Crozier RA, Ajit SK, Kaftan EJ, and Pausch MH (2007) MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J Neurosci 27:4492-4496.
39. Davenport AP, Bonner TI, Foord SM, Harmar AJ, Neubig RR, Pin JP, Spedding M, Kojima M, and Kangawa K (2005) International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev 57: 541-546.
40. de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A, Peters PJ, and van de Wetering M, et al. (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:293-297.
41. de Lecea L, Criado JR, Prospero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, Dunlop CL, Siggins GR, Henriksen SJ, and Sutcliffe JG (1996) A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381: 242-245.
42. Deng H, Hu H, and Fang Y (2012) Multiple tyrosine metabolites are GPR35 agonists. Sci Rep 2:373.
43. Dong X, Han S, Zylka MJ, Simon MI, and Anderson DJ (2001) A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106: 619-632.
44. Eggerickx D, Denef JF, Labbe O, Hayashi Y, Refetoff S, Vassart G, Parmentier M, and Libert F (1995) Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. Biochem J 309:837-843.
45. Eppig JT, Blake JA, Bult CJ, Kadin JA, and Richardson JE; Mouse Genome Database Group (2012) The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res 40 (Database issue):D881-D886.
46. Fallarini S, Magliulo L, Paoletti T, de Lalla C, and Lombardi G (2010) Expression of functional GPR35 in human iNKT cells. Biochem Biophys Res Commun 398: 420-425.
47. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, and Harmar AJ (2005) International Union of Pharmacology. XLVI. G proteincoupled receptor list. Pharmacol Rev 57:279-288.
48. Ford LA, Roelofs AJ, Anavi-Goffer S, Mowat L, Simpson DG, Irving AJ, Rogers MJ, Rajnicek AM, and Ross RA (2010) A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br J Pharmacol 160:762-771.
49. Geng Y, Xiong D, Mosyak L, Malito DL, Kniazeff J, Chen Y, Burmakina S, Quick M, Bush M, and Javitch JA, et al. (2012) Structure and functional interaction of the extracellular domain of human GABA(B) receptor GBR2. Nat Neurosci 15:970-978.
50. Gerrits H, van Ingen Schenau DS, Bakker NE, van Disseldorp AJ, Strik A, Hermens LS, Koenen TB, Krajnc-Franken MA, and Gossen JA (2008) Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Genesis 46:235-245.
51. Gloriam DE, Fredriksson R, and Schiöth HB (2007) The G protein-coupled receptor subset of the rat genome. BMC Genomics 8:338.
52. Godlewski G, Offertáler L, Wagner JA, and Kunos G (2009) Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat 89: 105-111.
53. Gong X, Carmon KS, Lin Q, Thomas A, Yi J, and Liu Q (2012) LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor. PLoS ONE 7:e37137.
54. Guo Y, Zhang W, Giroux C, Cai Y, Ekambaram P, Dilly AK, Hsu A, Zhou S, Maddipati KR, and Liu J, et al. (2011) Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J Biol Chem 286: 33832-33840.
55. Haitina T, Fredriksson R, Foord SM, Schiöth HB, and Gloriam DE (2009) The G protein-coupled receptor subset of the dog genome is more similar to that in humans than rodents. BMC Genomics 10:24.
56. Hamann J, Kwakkenbos MJ, de Jong EC, Heus H, Olsen AS, and van Lier RA (2003) Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence. Eur J Immunol 33:1365-1371.
57. Hamann J, Vogel B, van Schijndel GM, and van Lier RA (1996) The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 184: 1185-1189.
58. Han SK, Dong X, Hwang JI, Zylka MJ, Anderson DJ, and Simon MI (2002) Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RFamide-related peptides through the Galpha q/11 pathway. Proc Natl Acad Sci USA 99:14740-14745.
59. Hannedouche S, Zhang J, Yi T, Shen W, Nguyen D, Pereira JP, Guerini D, Baumgarten BU, Roggo S, and Wen B, et al. (2011) Oxysterols direct immune cell migration via EBI2. Nature 475:524-527.
60. Hansen KB, Rosenkilde MM, Knop FK, Wellner N, Diep TA, Rehfeld JF, Andersen UB, Holst JJ, and Hansen HS (2011) 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab 96: E1409-E1417.
61. Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, and Schuerer SC, et al. (2012) Crystal structure of a lipid G proteincoupled receptor. Science 335:851-855.
62. Hart R and Greaves DR (2010) Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 185:3728-3739.
63. Hase M, Yokomizo T, Shimizu T, and Nakamura M (2008) Characterization of an orphan G protein-coupled receptor, GPR20, that constitutively activates Gi proteins. J Biol Chem 283:12747-12755.
64. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, and Ling L (2004) Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429:188-193.
65. Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, and Irving AJ (2009) The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J 23:183-193.
66. Henstridge CM, Balenga NA, Schröder R, Kargl JK, Platzer W, Martini L, Arthur S, Penman J, Whistler JL, and Kostenis E, et al. (2010) GPR55 ligands promote receptor coupling to multiple signalling pathways. Br J Pharmacol 160:604-614.
67. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, and Tsujimoto G (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90-94.
68. Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, Gerlach LO, Storjohann L, Stidsen CE, Jones R, and Beck-Sickinger AG, et al. (2007) GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148:13-20.
69. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, and Schwartz TW (2004) Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279:53806-53817.
70. Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M, and Hsueh AJ (2000) The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol 14:1257-1271.
71. Hsu SY, Liang SG, and Hsueh AJ (1998) Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol Endocrinol 12: 1830-1845.
72. Hu H, Deng H, and Fang Y (2012) Label-free phenotypic profiling identified Dluciferin as a GPR35 agonist. PLoS ONE 7:e34934.
73. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, Kimura I, Leloire A, Liu N, and Iida K, et al. (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483:350-354.
74. Ignatov A, Robert J, Gregory-Evans C, and Schaller HC (2006) RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75. Br J Pharmacol 149:490-497.
75. Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R, and Shiota N, et al. (2004) Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279:26274-26279.
76. Ishiguro H, Onaivi ES, Horiuchi Y, Imai K, Komaki G, Ishikawa T, Suzuki M, Watanabe Y, Ando T, and Higuchi S, et al. (2011) Functional polymorphism in the GPR55 gene is associated with anorexia nervosa. Synapse 65:103-108.
77. Ivanova EA, Bechtold DA, Dupré SM, Brennand J, Barrett P, Luckman SM, and Loudon AS (2008) Altered metabolism in the melatonin-related receptor (GPR50) knockout mouse. Am J Physiol Endocrinol Metab 294:E176-E182.
78. Iwashita M, Makide K, Nonomura T, Misumi Y, Otani Y, Ishida M, Taguchi R, Tsujimoto M, Aoki J, and Arai H, et al. (2009) Synthesis and evaluation of lysophosphatidylserine analogues as inducers of mast cell degranulation. Potent activities of lysophosphatidylthreonine and its 2-deoxy derivative. J Med Chem 52: 5837-5863.
79. Jones PG, Nawoschik SP, Sreekumar K, Uveges AJ, Tseng E, Zhang L, Johnson J, He L, Paulsen JE, and Bates B, et al. (2007) Tissue distribution and functional analyses of the constitutively active orphan G protein coupled receptors, GPR26 and GPR78. Biochim Biophys Acta 1770:890-901.
80. Kamohara M, Matsuo A, Takasaki J, Kohda M, Matsumoto M, Matsumoto S, Soga T, Hiyama H, Kobori M, and Katou M (2005) Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides. Biochem Biophys Res Commun 330:1146-1152.
81. Kapas S, Catt KJ, and Clark AJ (1995) Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 270:25344-25347.
82. Kaplan MH, Smith DI, and Sundick RS (1993) Identification of a G protein coupled receptor induced in activated T cells. J Immunol 151:628-636.
83. Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, and Abood ME (2009) Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 284:29817-29827.
84. Kennedy SP, Sun D, Oleynek JJ, Hoth CF, Kong J, and Hill RJ (1998) Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem Biophys Res Commun 244:832-837.
85. Kirby HR, Maguire JJ, Colledge WH, and Davenport AP (2010) International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function. Pharmacol Rev 62:565-578.
86. Kitamura H, Makide K, Shuto A, Ikubo M, Inoue A, Suzuki K, Sato Y, Nakamura S, Otani Y, and Ohwada T, et al. (2012) GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position. J Biochem 151:511-518.
87. Kleist B, Xu L, Li G, and Kersten C (2011) Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int J Clin Exp Pathol 4: 327-335.
88. Klos A, Wende E, Wareham KJ, and Monk PN (2013) International Union of Pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol Rev 65:500-543.
89. Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, and Yasukawa M (2006) Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347:827-832.
90. Kostenis E (2004) Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands. J Cell Biochem 92:923-936.
91. Kotarsky K, Boketoft A, Bristulf J, Nilsson NE, Norberg A, Hansson S, Owman C, Sillard R, Leeb-Lundberg LM, and Olde B (2006) Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther 318:619-628.
92. Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, and Serhan CN (2012) Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 180:2018-2027.
93. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, and Serhan CN (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA 107:1660-1665.
94. Kuc D, Zgrajka W, Parada-Turska J, Urbanik-Sypniewska T, and Turski WA (2008) Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids 35: 503-505.
95. Lagerström MC and Schiöth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:339-357.
96. Lan H, Vassileva G, Corona A, Liu L, Baker H, Golovko A, Abbondanzo SJ, Hu W, Yang S, and Ning Y, et al. (2009) GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol 201:219-230.
97. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, and Mackie K (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 105:2699-2704.
98. Lauring B, Taggart AK, Tata JR, Dunbar R, Caro L, Cheng K, Chin J, Colletti SL, Cote J, Khalilieh S, et al. (2012) Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Sci Transl Med 4: 148-115.
99. Lauwers E, Landuyt B, Arckens L, Schoofs L, and Luyten W (2006) Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351:21-25.
100. Lee CW, Rivera R, Gardell S, Dubin AE, and Chun J (2006) GPR92 as a new G12/13-and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 281:23589-23597.
101. Lee MG, Dong X, Liu Q, Patel KN, Choi OH, Vonakis B, and Undem BJ (2008a) Agonists of the MAS-related gene (Mrgs) orphan receptors as novel mediators of mast cell-sensory nerve interactions. J Immunol 180:2251-2255.
102. Lee Z, Cheng CT, Zhang H, Subler MA, Wu J, Mukherjee A, Windle JJ, Chen CK, and Fang X (2008b) Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol Biol Cell 19:5435-5445.
103. Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, and Burger M (2010) CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology 129:536-546.
104. Lembo PM, Grazzini E, Groblewski T, O'Donnell D, Roy MO, Zhang J, Hoffert C, Cao J, Schmidt R, and Pelletier M, et al. (2002) Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat Neurosci 5:201-209.
105. Levoye A, Dam J, Ayoub MA, Guillaume JL, Couturier C, Delagrange P, and Jockers R (2006) The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J 25:3012-3023.
106. Liaw CW and Connolly DT (2009) Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42. DNA Cell Biol 28:555-560.
107. Lin HH, Stacey M, Saxby C, Knott V, Chaudhry Y, Evans D, Gordon S, McKnight AJ, Handford P, and Lea S (2001) Molecular analysis of the epidermal growth factorlike short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex. J Biol Chem 276:24160-24169.
108. Lin ME, Rivera RR, and Chun J (2012) Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. J Biol Chem 287:17608-17617.
109. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, and Hoener MC (2005) Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85:372-385.
110. Liu C, Yang XV, Wu J, Kuei C, Mani NS, Zhang L, Yu J, Sutton SW, Qin N, and Banie H, et al. (2011) Oxysterols direct B-cell migration through EBI2. Nature 475:519-523.
111. Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y, Weng HJ, and Geng Y, et al. (2009) Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139:1353-1365.
112. Luangsay S, Wittamer V, Bondue B, De Henau O, Rouger L, Brait M, Franssen JD, de Nadai P, Huaux F, and Parmentier M (2009) Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol 183:6489-6499.
113. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, and Seuwen K (2003) Proton-sensing G-protein-coupled receptors. Nature 425: 93-98.
114. Luo R, Jeong SJ, Jin Z, Strokes N, Li S, and Piao X (2011) G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination. Proc Natl Acad Sci USA 108:12925-12930.
115. Maekawa A, Balestrieri B, Austen KF, and Kanaoka Y (2009) GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci USA 106:11685-11690.
116. Maguire JJ, Parker WA, Foord SM, Bonner TI, Neubig RR, and Davenport AP (2009) International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature. Pharmacol Rev 61:1-8.
117. Malik L, Kelly NM, Ma JN, Currier EA, Burstein ES, and Olsson R (2009) Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis. Bioorg Med Chem Lett 19:1729-1732.
118. Marazziti D, Di Pietro C, Golini E, Mandillo S, Matteoni R, and Tocchini-Valentini GP (2009) Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor. FASEB J 23:1978-1987.
119. Marazziti D, Di Pietro C, Mandillo S, Golini E, Matteoni R, and Tocchini-Valentini GP (2011) Absence of the GPR37/PAEL receptor impairs striatal Akt and ERK2 phosphorylation, DeltaFosB expression, and conditioned place preference to amphetamine and cocaine. FASEB J 25:2071-2081.
120. Marazziti D, Mandillo S, Di Pietro C, Golini E, Matteoni R, and Tocchini-Valentini GP (2007) GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs. Proc Natl Acad Sci USA 104:9846-9851.
121. Mårtensson UE, Salehi SA, Windahl S, Gomez MF, Swärd K, Daszkiewicz-Nilsson J, Wendt A, Andersson N, Hellstrand P, and Grände PO, et al. (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150:687-698.
122. Maruyama T, Miyamoto Y, Nakamura T, Tamai Y, Okada H, Sugiyama E, Nakamura T, Itadani H, and Tanaka K (2002) Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 298:714-719.
123. Matsumoto M, Nomura T, Momose K, Ikeda Y, Kondou Y, Akiho H, Togami J, Kimura Y, Okada M, and Yamaguchi T (1996) Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 271:27217-27220.
124. McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, and Bradshaw HB (2010) N-Arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 11:44.
125. 9)-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol 165:2414-2424.
126. Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, John H, Richter R, Schleuder D, Meyer M, and Forssmann WG (2003) Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett 555: 495-499.
127. Meyerzu Heringdorf D and Jakobs KH (2007) Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 1768:923-940.
128. Milasta S, Pediani J, Appelbe S, Trim S, Wyatt M, Cox P, Fidock M, and Milligan G (2006) Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD. Mol Pharmacol 69:479-491.
129. Moechars D, Depoortere I, Moreaux B, de Smet B, Goris I, Hoskens L, Daneels G, Kass S, Ver Donck L, and Peeters T, et al. (2006) Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 131:1131-1141.
130. Morgan K, Conklin D, Pawson AJ, Sellar R, Ott TR, and Millar RP (2003) A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology 144:423-436.
131. Murakami M, Shiraishi A, Tabata K, and Fujita N (2008) Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. Biochem Biophys Res Commun 371:707-712.
132. Murakami N, Yokomizo T, Okuno T, and Shimizu T (2004) G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 279:42484-42491.
133. Neubig RR (2010) Mind your salts: when the inactive constituent isn't. Mol Pharmacol 78:558-559.
134. Ning Y, O'Neill K, Lan H, Pang L, Shan LX, Hawes BE, and Hedrick JA (2008) Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol 155: 1056-1065.
135. Noguchi K, Ishii S, and Shimizu T (2003) Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278:25600-25606.
136. Nonaka Y, Hiramoto T, and Fujita N (2005) Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem Biophys Res Commun 337:281-288.
137. Nothacker HP, Wang Z, Zeng H, Mahata SK, O'Connor DT, and Civelli O (2005) Proadrenomedullin N-terminal peptide and cortistatin activation of MrgX2 receptor is based on a common structural motif. Eur J Pharmacol 519:191-193.
138. O'Sullivan ML, de Wit J, Savas JN, Comoletti D, Otto-Hitt S, Yates JR 3rd, and Ghosh A (2012) FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development. Neuron 73:903-910.
139. Offermanns S, Colletti SL, Lovenberg TW, Semple G, Wise A, and IJzerman AP (2011) International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B). Pharmacol Rev 63:269-290.
140. Oka S, Kimura S, Toshida T, Ota R, Yamashita A, and Sugiura T (2010a) Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells. J Biochem 147:671-678.
141. Oka S, Nakajima K, Yamashita A, Kishimoto S, and Sugiura T (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362:928-934.
142. Oka S, Ota R, Shima M, Yamashita A, and Sugiura T (2010b) GPR35 is a novel lysophosphatidic acid receptor. Biochem Biophys Res Commun 395:232-237.
143. Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, and Sugiura T (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. J Biochem 145:13-20.
144. Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, and Ducy P, et al. (2011) Endocrine regulation of male fertility by the skeleton. Cell 144:796-809.
145. Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, and Tang-Christensen M, et al. (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:167-175.
146. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW, and Ravichandran KS (2007) BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450: 430-434.
147. Pasternack SM, von Kügelgen I, Al Aboud K, Lee YA, Rüschendorf F, Voss K, Hillmer AM, Molderings GJ, Franz T, and Ramirez A, et al. (2008) G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 40:329-334.
148. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, and Mackie K, et al. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB. Pharmacol Rev 62:588-631.
149. Petersen PS, Jin C, Madsen AN, Rasmussen M, Kuhre R, Egerod KL, Nielsen LB, Schwartz TW, and Holst B (2011) Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism. FASEB J 25:3803-3814.
150. Pi M, Parrill AL, and Quarles LD (2010) GPRC6A mediates the non-genomic effects of steroids. J Biol Chem 285:39953-39964.
151. Pi M, Wu Y, Lenchik NI, Gerling I, and Quarles LD (2012) GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets. Endocrinology 153:4608-4615.
152. Pi M, Wu Y, and Quarles LD (2011) GPRC6A mediates responses to osteocalcin in b-cells in vitro and pancreas in vivo. J Bone Miner Res 26:1680-1683.
153. Piñeiro R, Maffucci T, and Falasca M (2011) The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene 30: 142-152.
154. Pitkin SL, Maguire JJ, Bonner TI, and Davenport AP (2010) International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacol Rev 62:331-342.
155. Popovics P and Stewart AJ (2011) GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci 68:85-95.
156. Prossnitz ER and Barton M (2011) The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7:715-726.
157. Qian YM, Haino M, Kelly K, and Song WC (1999) Structural characterization of mouse CD97 and study of its specific interaction with the murine decayaccelerating factor (DAF, CD55). Immunology 98:303-311.
158. Qin Y, Verdegaal EM, Siderius M, Bebelman JP, Smit MJ, Leurs R, Willemze R, Tensen CP, and Osanto S (2011) Quantitative expression profiling of G-proteincoupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target. Pigment Cell Melanoma Res 24:207-218.
159. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, and Lefkowitz RJ (2010) Beta-arrestinbut not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci USA 107:628-632.
160. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, and Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630.
161. Rezgaoui M, Süsens U, Ignatov A, Gelderblom M, Glassmeier G, Franke I, Urny J, Imai Y, Takahashi R, and Schaller HC (2006) The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37. J Cell Sci 119:542-549.
162. Ritscher L, Engemaier E, Stäubert C, Liebscher I, Schmidt P, Hermsdorf T, Römpler H, Schulz A, and Schöneberg T (2012) The ligand specificity of the G-proteincoupled receptor GPR34. Biochem J 443:841-850.
163. Robas N, Mead E, and Fidock M (2003) MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J Biol Chem 278:44400-44404.
164. Römpler H, Schulz A, Pitra C, Coop G, Przeworski M, Pääbo S, and Schöneberg T (2005) The rise and fall of the chemoattractant receptor GPR33. J Biol Chem 280: 31068-31075.
165. Rose PM, Lynch JS, Frazier ST, Fisher SM, Chung W, Battaglino P, Fathi Z, Leibel R, and Fernandes P (1997) Molecular genetic analysis of a human neuropeptide Y receptor. The human homolog of the murine "Y5" receptor may be a pseudogene. J Biol Chem 272:3622-3627.
166. Rosenkilde MM, Benned-Jensen T, Andersen H, Holst PJ, Kledal TN, Lüttichau HR, Larsen JK, Christensen JP, and Schwartz TW (2006) Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J Biol Chem 281:13199-13208.
167. Ross RA (2009) The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30: 156-163.
168. Ross RA (2011) L-a-lysophosphatidylinositol meets GPR55: a deadly relationship. Trends Pharmacol Sci 32:265-269.
169. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, and Bader M, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100:8258-8263.
170. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, and O'Dowd BF (1999) Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64:193-198.
171. Seal RL, Gordon SM, Lush MJ, Wright MW, and Bruford EA (2011) genenames.org: the HGNC resources in 2011. Nucleic Acids Res 39:D514-D519.
172. Seuwen K, Ludwig MG, and Wolf RM (2006) Receptors for protons or lipid messengers or both? J Recept Signal Transduct Res 26:599-610.
173. Shah U and Kowalski TJ (2010) GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. Vitam Horm 84:415-448.
174. Sharir H and Abood ME (2010) Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 126:301-313.
175. Sharir H, Zinger A, Nevo A, Sekler I, and Hershfinkel M (2010) Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair. J Biol Chem 285:26097-26106.
176. Sharman JL, Mpamhanga CP, Spedding M, Germain P, Staels B, Dacquet C, Laudet V, and Harmar AJ; NC-IUPHAR (2011) IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data. Nucleic Acids Res 39 (Database issue):D534-D538.
177. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, and Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
178. Shinohara T, Harada M, Ogi K, Maruyama M, Fujii R, Tanaka H, Fukusumi S, Komatsu H, Hosoya M, and Noguchi Y, et al. (2004) Identification of a G proteincoupled receptor specifically responsive to beta-alanine. J Biol Chem 279: 23559-23564.
179. Sierro F, Biben C, Martínez-Muñoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, and Batten M, et al. (2007) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 104:14759-14764.
180. Silva JP, Lelianova VG, Ermolyuk YS, Vysokov N, Hitchen PG, Berninghausen O, Rahman MA, Zangrandi A, Fidalgo S, and Tonevitsky AG, et al. (2011) Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proc Natl Acad Sci USA 108: 12113-12118.
181. Singh G and Davenport AP (2006) Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system. Br J Pharmacol 148:1033-1041.
182. Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, and Yoshida S, et al. (2005) Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326:744-751.
183. Solinski HJ, Boekhoff I, Bouvier M, Gudermann T, and Breit A (2010) Sensory neuron-specific MAS-related gene-X1 receptors resist agonist-promoted endocytosis. Mol Pharmacol 78:249-259.
184. Southern C, Cook JM, Neetoo-Isseljee Z, Taylor DL, Kettleborough CA, Merritt A, Bassoni DL, Raab WJ, Quinn E, and Wehrman TS, et al. (2013) Screening b-arrestin recruitment for the identification of natural ligands for orphan Gprotein-coupled receptors. J Biomol Screen DOI: 10.1177/1087057113475480.
185. Stacey M, Chang GW, Davies JQ, Kwakkenbos MJ, Sanderson RD, Hamann J, Gordon S, and Lin HH (2003) The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 102:2916-2924.
186. Starbäck P, Wraith A, Eriksson H, and Larhammar D (2000) Neuropeptide Y receptor gene y6: multiple deaths or resurrections? Biochem Biophys Res Commun 277:264-269.
187. Stoddart LA, Smith NJ, and Milligan G (2008) International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol Rev 60:405-417.
188. Strotmann R, Schröck K, Böselt I, Stäubert C, Russ A, and Schöneberg T (2011) Evolution of GPCR: change and continuity. Mol Cell Endocrinol 331:170-178.
189. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
190. Sugo T, Tachimoto H, Chikatsu T, Murakami Y, Kikukawa Y, Sato S, Kikuchi K, Nagi T, Harada M, and Ogi K, et al. (2006) Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun 341:1078-1087.
191. Sumida H, Noguchi K, Kihara Y, Abe M, Yanagida K, Hamano F, Sato S, Tamaki K, Morishita Y, and Kano MR, et al. (2010) LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood 116:5060-5070.
192. Tabata K, Baba K, Shiraishi A, Ito M, and Fujita N (2007) The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 363:861-866.
193. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, Ren N, Kaplan R, Wu K, and Wu TJ, et al. (2005) (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 280:26649-26652.
194. Taniguchi Y, Tonai-Kachi H, and Shinjo K (2006) Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 580:5003-5008.
195. Thathiah A, Spittaels K, Hoffmann M, Staes M, Cohen A, Horré K, Vanbrabant M, Coun F, Baekelandt V, and Delacourte A, et al. (2009) The orphan G proteincoupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science 323:946-951.
196. Thomas P, Pang Y, Filardo EJ, and Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632.
197. Tobo M, Tomura H, Mogi C, Wang JQ, Liu JP, Komachi M, Damirin A, Kimura T, Murata N, and Kurose H, et al. (2007) Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms. Cell Signal 19:1745-1753.
198. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, Meer E, and Peti-Peterdi J (2008) Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 118:2526-2534.
199. Toyooka M, Tujii T, and Takeda S (2009) The N-terminal domain of GPR61, an orphan G-protein-coupled receptor, is essential for its constitutive activity. J Neurosci Res 87:1329-1333.
200. Tremblay F, Perreault M, Klaman LD, Tobin JF, Smith E, and Gimeno RE (2007) Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148:501-506.
201. Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, and Offermanns S (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9:352-355.
202. Uddin M and Levy BD (2011) Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res 50:75-88.
203. Uhlenbrock K, Gassenhuber H, and Kostenis E (2002) Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell Signal 14:941-953.
204. Vanti WB, Muglia P, Nguyen T, Cheng R, Kennedy JL, George SR, and O'Dowd BF (2003) Discovery of a null mutation in a human trace amine receptor gene. Genomics 82:531-536.
205. Venkataraman C and Kuo F (2005) The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking. Immunol Lett 101:144-153.
206. Waldeck-Weiermair M, Zoratti C, Osibow K, Balenga N, Goessnitzer E, Waldhoer M, Malli R, and Graier WF (2008) Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptortriggered repression. J Cell Sci 121:1704-1717.
207. Wandel E, Saalbach A, Sittig D, Gebhardt C, and Aust G (2012) Thy-1 (CD90) is an interacting partner for CD97 on activated endothelial cells. J Immunol 188: 1442-1450.
208. Wang C, Dehghani B, Magrisso IJ, Rick EA, Bonhomme E, Cody DB, Elenich LA, Subramanian S, Murphy SJ, and Kelly MJ, et al. (2008) GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol 22:636-648.
209. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, and Ling L (2006a) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281:22021-22028.
210. Wang J, Wu X, Simonavicius N, Tian H, and Ling L (2006b) Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem 281: 34457-34464. Epub 2006 Sep 11.
211. Wang JQ, Kon J, Mogi C, Tobo M, Damirin A, Sato K, Komachi M, Malchinkhuu E, Murata N, and Kimura T, et al. (2004) TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J Biol Chem 279:45626-45633.
212. Webb TE, Kaplan MG, and Barnard EA (1996) Identification of 6H1 as a P2Y purinoceptor: P2Y5. Biochem Biophys Res Commun 219:105-110.
213. Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ, Ross RA, and Rogers MJ (2009) The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci USA 106:16511-16516.
214. Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, Siess W, Parrill AL, Tigyi G, and Fujiwara Y (2009) Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem 284: 17304-17319.
215. Wilson SR, Gerhold KA, Bifolck-Fisher A, Liu Q, Patel KN, Dong X, and Bautista DM (2011) TRPA1 is required for histamine-independent, Mas-related G proteincoupled receptor-mediated itch. Nat Neurosci 14:595-602.
216. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R, Blanpain C, and Detheux M, et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198:977-985.
217. Witte ON, Kabarowski JH, Xu Y, Le LQ, and Zhu K (2005) Retraction. Science 307: 206.
218. Wyder L, Suply T, Ricoux B, Billy E, Schnell C, Baumgarten BU, Maira SM, Koelbing C, Ferretti M, and Kinzel B, et al. (2011) Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor. Angiogenesis 14: 533-544.
219. Xu L and Hynes RO (2007) GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment. Cell Cycle 6:160-165.
220. Yanagida K, Masago K, Nakanishi H, Kihara Y, Hamano F, Tajima Y, Taguchi R, Shimizu T, and Ishii S (2009) Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J Biol Chem 284:17731-17741.
221. Yang LV, Radu CG, Roy M, Lee S, McLaughlin J, Teitell MA, Iruela-Arispe ML, and Witte ON (2007) Vascular abnormalities in mice deficient for the G proteincoupled receptor GPR4 that functions as a pH sensor. Mol Cell Biol 27:1334-1347.
222. Yang Y, Fu A, Wu X, and Reagan JD (2012) GPR35 is a target of the loop diuretic drugs bumetanide and furosemide. Pharmacology 89:13-17.
223. Yasuda S, Miyazaki T, Munechika K, Yamashita M, Ikeda Y, and Kamizono A (2007) Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum. J Recept Signal Transduct Res 27:235-246.
224. Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, Nguyen DG, Caldwell JS, and Chen YA (2009) Lipid G protein-coupled receptor ligand identification using betaarrestin PathHunter assay. J Biol Chem 284:12328-12338.
225. Yoshida M, Miyazato M, and Kangawa K (2012) Orphan GPCRs and methods for identifying their ligands. Methods Enzymol 514:33-44.
226. Yoshimura T and Oppenheim JJ (2011) Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res 317:674-684.
227. Zabel BA, Nakae S, Zúñiga L, Kim JY, Ohyama T, Alt C, Pan J, Suto H, Soler D, and Allen SJ, et al. (2008) Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 205:2207-2220.
228. Zabel BA, Silverio AM, and Butcher EC (2005) Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 174:244-251.
229. Zhang JV, Klein C, Ren PG, Kass S, Ver Donck L, Moechars D, and Hsueh AJ (2007) Response to Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 315:766d.
230. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, and Hsueh AJ (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-999.
231. Zhang Y, Wang Z, Parks GS, and Civelli O (2011) Novel neuropeptides as ligands of orphan G protein-coupled receptors. Curr Pharm Des 17:2626-2631.
232. Zhang ZD, Frankish A, Hunt T, Harrow J, and Gerstein M (2010) Identification and analysis of unitary pseudogenes: historic and contemporary gene losses in humans and other primates. Genome Biol 11:R26.
233. Zhao P, Sharir H, Kapur A, Cowan A, Geller EB, Adler MW, Seltzman HH, Reggio PH, Heynen-Genel S, and Sauer M, et al. (2010) Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and b-arrestin2 with antinociceptive activity. Mol Pharmacol 78:560-568.
234. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, Kabarowski JH, Witte ON, and Xu Y (2001) Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276:41325-41335 [Retraction, 2005].
235. Zhu Y and Murakami F (2012) Chemokine CXCL12 and its receptors in the developing central nervous system: emerging themes and future perspectives. Dev Neurobiol 72:1349-1362.